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Abstrak
Latar Belakang: Protein dalam kedelai, β conglycinin mempunyai efek menekan nafsu makan melalui 
stimulasi Kolesistokinin. Kolesistokinin adalah hormon yang dilepaskan di saluran pencernaan dipicu 
oleh asupan protein dan berefek menekan nafsu makan untuk jangka pendek. Detam 1 adalah jenis kedelai 
berkualitas tinggi berdasarkan dengan Menteri Pertanian Indonesia. Ekstrak protein kedelai Detam 1 
oleh Deak metode mengandung kadar β conglycinin yang tinggi. Tujuan dari penelitian ini adalah untuk 
mengetahui pengaruh ekstrak protein kedelai Detam 1 metode Deak dalam menurunkan asupan makanan, 
berat badan, dan kadar CCK plasma selama 14 dan 28 hari pada berbagai dosis dan pola pemberian 
pada tikus Wistar jantan. 
Metode: Terdapat sebelas kelompok perlakuan (n=3), kelompok dosis (5mg/1x//hari, 10mg/1x/hari, 
20mg/1x/hari), (2,5mg/2x/hari, 5mg/2x/hari, 10mg/2x/hari) dan (1,7mg/3x/hari, 3,4mg/3x/ hari, 6,7mg/3x/
hari), kelompok kontrol negatif (akuades) dan kelompok positif kontrol (Sibutramine). asupan makanan 
(g), berat badan (g) dan pengukuran tingkat Cholecystokinin plasma dengan metode ELISA (ng / ml). 
Hasil:  Hasil penelitian menunjukkan bahwa persentase penurunan asupan makanan yang terbaik adalah: 
kelompok 3,4mg/3x/hari (p <0,05), penghambatan berat badan selama 14 hari: kelompok 10 mg/1x/hari, 
selama 28 hari: kelompok 1,7mg/3x/hari (p <0,05), peningkatan kadar Kolesistokinin plasma: kelompok 
20 mg / 1 x / hari (p <0,05). 
Simpulan: Dosis dan pola pemberian terbaik untuk menghambat berat badan selama 14 hari adalah 
ekstrak 10 mg sekali sehari di pagi hari, selama 28 hari adalah 1,7 mg tiga kali sehari. (Health Science 
Journal of Indonesia 2016;7:17-26)
Kata kunci: Kedelai Detam 1 -dosis efektif - berat badan - kolesistokinin
Abstract
Background: Protein in soybean, β conglycinin is responsible for anti-obesity effects by suppressing 
appetite via stimulation of Cholecystokinin. Cholecystokinin is a hormone released in the digestive tract 
in response to the intake of protein and suppress appetite for short-term. Detam 1 variety is a high-quality 
soybean according to the Minister of Agriculture of Indonesia. Soybean protein extract Detam 1 by Deak 
method  contains high levels of β conglycinin. The purpose of this study was to determine the effective dose 
of  protein extract Detam 1 soybean Deak Method (PEDSDM) in reducing food intake, regulate body weight, 
and plasma CCK level for 14 and 28 days at various dosage and pattern of treatment on male Wistar rats. 
Methods: There were eleven groups of treatment (n = 3), administrated with  extracts at 5 mg/1x/day, 10 
mg/1x/day, 20 mg/1x/day, 2.5 mg/2x/day, 5 mg/2x/day, 10 mg/2x/day and 1.7mg/3x/day, 3.4mg/3x/day, 
6.7 mg/3x/day, negative control group (distilled water) and positive control group (Sibutramine). Food 
intake (g), weight loss (g) and measurement of plasma Cholecystokinin levels by ELISA (ng /ml) 
Results: The results showed that the highest percentage decrease in food intake is: group 3.4mg /3x/ day 
(p <0.05), inhibition weight gain for 14 days: group 10 mg /1x/ day, for 28 days: group 1.7 mg/3x/day (p 
<0.05), increased plasma Cholecystokinin levels: group 20 mg /1x/day (p <0.05). 
Conclusions:  The effective dose and pattern administrating the rats for 14 days is extract of 10 mg once a day 
in the morning, for 28 days  is 1.7 mg three times a day. (Health Science Journal of Indonesia 2016;7:17-26)
Keywords:  Soybean var Detam 1 -effective dose - body weight - Cholecystokinin
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The worldwide prevalence of obesity has nearly 
doubled between 1980 and 2008. In 2008, 10% of 
men and 14% of women in the world were obese 
(BMI ≥30 kg/m2), compared with 5% for men and 
8% for women in 1980. An estimated 205 million 
men and 297 million women over the age of 20 were 
obese – a total of more than half a billion adults 
worldwide.1 This condition should be overcome 
because obesity can cause many side effects. The 
solution is to discover good  nutrition sources that can 
reduce body weight, like soybean. Soybean (Glycine 
max L. merr) is known for the health benefits, good 
dietary supplements for both humans and animals. 
Nutritional study showed that soybean protein 
produced higher thermogenic and satiety effect than 
that of carbohydrate. This fact made soybean as a 
good nutrition source for reducing obesity.2 
Elvira de Mejia, assistant professor of food science 
and human nutrition in University of Illinois at 
Urbana Champaign, found that soy did have an effect 
on mechanisms which similar with Leptin.3,4  Leptin 
is a hormone which is produced in our adipose tissue 
that interacts with receptors in the brain and signals 
us that we’re full so we stop eating and hormones 
that are induced in the body to help us degrade lipids 
and reduce body weight, by boosting metabolism 
and not by reducing food intake.3,4 According to Liu 
study, six-month supplementation of soy protein 
with isoflavones had a mild favorable effect on body 
composition in postmenopausal women.5 
Previous studies reported that, β-conglycinin peptone 
which contains abundantly in soybean, stimulating 
endogenous Cholecystokinin (CCK) to transduction 
signal in intestinal cells that suppressed appetite and 
food intakes.6,7 The fragment from 51 to 63 of the 
β-subunit (β51-63) of β-conglycinin had the strongest 
binding activity to stimulate releasing CCK and 
appetite suppression.7 CCK is an important hormonal 
regulator of the digestive process. CCK is released in 
the digestive tract in response to the intake of protein 
and fat and suppress appetite for short-term. The 
physiological actions of CCK include stimulation 
of pancreatic secretion and gallbladder contraction, 
regulation of gastric emptying, and induction of 
satiety. Therefore, the ability to stimulate CCK has 
made β-conglycinin in soybean as one of the important 
therapy in obesity treatment.8
Protein  extracts of  Detam 1 soybean (Glycine max 
L.Merr)  Deak method (PEDSDM) contained protein 
level of 41,82% from its dry weight, measured 
by Kjeldahl methods; alkaloids (Wagner) and 
triterpenoids by qualitative phytochemical test. The 
PEDSDM  was reported for the best in decreasing 
the food intake compared to other extracts on 
male Wistar rats, which administered PEDSDM 80 
mg/kgBW~20 mg/250g/rat (the food intake and 
bodyweight at baseline were (21,77 + 2,82)g and 
(238,33 + 21,38)g, and at endline were (12,6 + 0,89)
g  and (189,33 + 27,30)g, p = 0,022), and (p = 0,020), 
respectively.9,10  But we  don’t have any data about 
the effective dose and the best pattern of PEDSDM 
administration, to complete these data, therefore this 
study need to be done.  
There are several kinds of extraction methods to 
produce β-conglycinin. Deak method is the procedure 
to produce protein fractions (> 90% protein) which is 
rich in either glycinin or β-conglycinin by employing 
CaCl2 and NaHSO3.11 Deak method was proved to 
produce  β-conglycinin better than other methods, 
measured by SDS PAGE and CBB staining. The 
proportion of   β-conglycinin level  (7 S  Globulin) 
in Detam 1 soybean seed is 27% while β-conglycinin 
sub unit  β (54 kDa) in PEDSDM is 25 : 31,7 DU= 
78,86 % from total β-conglycinin.12 
The duration effect of CCK in suppressing appetite 
is short, begin in 15 minutes after induction by 
peptone, reached  the peak level in 45 minutes then 
sustained for 2 hours.6,7  So that we want to know 
the best administered of PEDSDM to induce CCK 
secretion due to regulating body weight.
The aim of this study is to determine the effective 
dose and pattern of the  PEDSDM administration 
on food intake, body weight and CCK level in male 
Wistar rats. 
METHODS
Soybean seed variety Detam 1, a high quality of black 
soybean approved by the Agricultural Ministry of 
Republic of Indonesia were cultivated on Research 
and Development Unit of  Legumes and Tubers’ in 
Malang, East Java Indonesia.9 Its protein content is 
higher than other soybean varieties 45.36%.  Then 
Detam 1 soybean were extracted to be PEDSDM 
using Deak’s method.11
The procedures of Deak’s method is as explained 
below. Defatted soy flour of 100 g was extracted 
using deionized water with ratio of 1:15 (w/v) at pH 
8.5 adjusted with 2 N NaOH. The slurry was stirred 
for 1 h and centrifuged at 14,000 g and 15 oC for 30 
min. The protein extract (first protein extract) was 
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decanted. The extract was then added with sufficient 
NaHSO3 and CaCl2 to obtain concentration of either 
SO2 and Ca2+ to 5 mM and the pH was adjusted 
to 6.4 with 2 N HCl. The slurry was stored at 4 oC 
for 12-16 h, then centrifuged at 14,000 g for 30 min 
at 4 oC. A glycinin-rich fraction was obtained as the 
precipitated curd, which was neutralized and treated 
as described on Wu procedure. The supernatant 
(second protein extract) was adjusted to pH 4.8 with 
HCl. Then it was stirred for 1 hour and centrifuged 
at 14,000 g and 4 oC for 30 min. A β - conglycinin-
rich fraction was obtained as the precipitated curd 
and treated as described previously. The amount 
of supernatant (whey) was determined and sampled. 
Freeze-drying steps were modified to evaporation 
process in cycling evaporator at 30 oC until the solution 
extracts become thick liquid. Samples were placed in 
sealed containers and stored at 4 oC up to analysis. There 
are two steps in Deak’s procedure i.e. D4C (in 4 oC) and 
DRT (in 25 oC).11 The Deak β -conglycinin-rich fraction 
D4C (the methods which performed in this study) 
comprised 23.1% of the solids, 37.1% of the protein 
and 37.5% of the isoflavones in the starting soy flour. 
PDSDM protein purity was > 80%. Their D4C method 
produced 85.6% β-conglycinin and 14.4% glycinin. 
The β–conglycinin subunit consisted of 27.3% subunit 
α’, 38.0% subunit α‘’ and 34.7% subunit α.12 
Animal Research Procedure
The number of experimental animals were calculated 
by Ali Hanafiah formula,13 that 3 rats each groups, 
with 11 different group of treatments is enough for this 
experimental. This study  has approved by University 
Christian of Maranatha Ethics Commission, SKEP 
no 148/KEP FK UKM-RSI/V/2009. Thirty three 
male Wistar rats, aged 8-10 weeks, weighing between 
220-250 g, after aclimatization for 7 days, they were 
randomly divided into 11 groups, then administrated 
with protein extract of Detam 1 soybean for 28 days. 
Group A, Negative control B. PEDSDM 5 mg/rat/
day, once a day, C. PEDSDM 2.5 mg/rat /day, twice 
a day, D. PEDSDM 1.7 mg/rat/day three times a day, 
E. PEDSDM 10 mg/rat/day, once a day, F. PEDSDM 
5 mg/rat/day, twice a day, G. PEDSDM 3.4 mg/rat/
day three times a day, H. PEDSDM 20 mg/rat/day, 
once a day, I. PEDSDM 10 mg/rat/day, twice a day, 
J. PEDSDM 6.7 mg/rat/day three times a day, K. 
Sibutramine 0.18 mg/rat/day, as a positive control. 
All rats and the rest of fed were weighed once in 
two days. The parameters measured were daily food 
intake, body weight, once in 2 days and CCK plasma 
level after 28 days of treatments.
The food intake which were given ad libitum was 
Complete Feed Grains CP 551, which is produced 
by PT Charoen Pokphand Indonesia; contains 310 - 
320 kkal/per 100g, with protein contents: 18.5 - 20.5 %. 
The treatment dose in this study, PEDSDM  were 
calculated based on Nishy’s formula6 (10 mg/ kg or 
2.5 mg / 250g), the rats were administered 5, 10 and 
20 mg once daily at 08.00 a.m, twice at 08.00 a.m 
and 08.00 p.m, 3x daily at 08.00 a.m, 16.00 p.m  and 
24.00 p.m via oral gastric sonde.
Statistical Analysis
Data of food intake, body weight and CCK were analysed 
using ANOVA test, followed by Duncan HSD test.
Ethical approval from Ethical Review Board of 
Faculty of Medicine, Maranatha Christian University 
with No. 148/KEP FK UKM-RSI/V/2009.
RESULTS
After analysed distribution normality with Shapiro 
- Wilk test, it was found that most of the data were 
normally distributed (p > 0.05), then parametric 
statistical tests can be used
 
Effect of Soy Protein Extract Variety Detam 1  on 
Male Wistar rats feed intake
Table 1 showed the feed intake on male Wistar rats at 
baseline (day 0) and endline (day 28).
As seen in Figure 1, the result of Negative control 
group along 28 days of treatment,  the food intake was 
between 19.5g/day-25g/day, baseline 22.00  and endline 
21.5 with p>0.05. Group B,  the least food intake was 
15 g/day, the highest was 24g/day and  decreased after 
14 days, baseline 23.25 and endline 16.5 with p>0.05. 
Group D food intake was between 15g/day-22.9g/day 
and decreased after 7 days, baseline 21.33 and endline 
16.0, p>0.05.  The highest food intake of group G  was 
24.9g/day  while the least food intake was 12 g/day, it 
was very low and tend to decrease after 7 days, baseline 
24.00  and endline 17.0, p>0.05. Group K was between 
14g/day-24g/day and decreased after 7 days, baseline 
20.33  and endline 17.33 with p>0.05.
In general, all groups of treatment showed that the feed 
intake at endline tended to be decreased, however, the 
best was group B (PEDSDM 5 mg/rat 1x day ), the 
second was D (PEDSDM 1.7 mg/rat  3 x day ) and the 
third was G (PEDSDM 3.4 mg/rat  3 x day) (p<0.05).
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Table 1. Description and Food Intake Paired t test on Male Wistar rats
Group No Treatment Animal FeedBaseline
Animal Feed
Endline
Changes
(Δ %)
p
Value
 (sd)  (sd)
A NC, 2 ml aquadest 22.00 (2.16) 21.50 (2.38) 2.27 %  0.182
B 5 mg/rat/day, once a day 23.25 (1.71) 16.50 (1.29) 29.3 %  0. 4
C 2.5 mg/rat/day, twice a day 21.00 (1.73) 18.67 (0.58) 11.9 %  0.346
D 1.7 mg/rat/day three times a day 21.33 (3.21) 16.00 (6.24) 24.98 %   0.18
E 10 mg/rat/day, once a day 23.00 (2.45) 19.25 (3.50) 16.3  %  0.83
F 5 mg/rat/day, twice a day 22.00 (1.00) 21.00 (2.65) 4.54 %   0.796
G 3.4 mg/rat/day three times a day 24.00 (1.00) 17.00 (4.36) 29.16 %  0 .  2
H 20 mg/rat/day, once a day 24.50 (1.00) 22.25 (0.96) 9.18 %   0.281
I 10 mg/rat/day, twice a day 23.67 (2.31) 22.33 (3.06) 5.66 %   0.666
J 6.7 mg/rat/day three times a day 20.00 (1.00) 16.67 (4.93) 16.65 %  0 .15 
K PC, Sibutramine 0.18 mg/rat/day 20.33 (5.03) 17.33 (4.04) 14.75 %   0.162
p Value 0.229 0.112   
Description :   NC = Negative Control   PC = Positive Control
% Change (Δ )= (The average and standard deviation sd  feed intake at endline - feed intake at baseline) / baseline feed intake x 100 %
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Figure 1.  Profile of  Food Intake in each group during 28 days 
Legend: 
igure 1. Profil  of  Food Intake in each group during 28 days
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Effect of PEDSDM on Body Weight of Male 
Wistar rats
This study was conducted to find out the effect of 
PEDSDM on the  inhibition of weight gain in Male 
Wistar rats during 28 days. The description of body 
weight in Male Wistar rats after 14 days, 28 days of 
treatments can be seen in table 2. 
Table 2 showed that between the treatment groups 
there was no significant difference in average of 
bodyweight at end line, 0 days and 14 days (p > 
0.05). Statistical analysis showed F count 14 days 
was 2.774 (p =0.018), while F count 28 days was 
5.870 (p < 0.001), which mean there was an effect 
of the  treatment. There was significant  changes of 
percentage between 14 days and 28 days (p< 0.05).  
The results of the positive control group K Sibutramin 
were not in the same column with group A, negative 
control, so it conclude that the research methods 
used are considered valid. Most of the treatment 
group were not in the same column with group A, 
this suggests that the group treatment had different 
effects with Negative control, and was assumed that 
the treatment groups had potencies to control weight 
gain.  Treatment Group E, H, I, F and B were in the 
same column with the comparison group K, indicated 
that this treatment groups had a similar effect with 
sibutramine, after 14 days of treatment (Table 3).
Table 2. Body Weight of Male Wistar rats in each group of treatment every two weeks
Group of 
Treatments BW 0 d (g)              BW 14 d (g) Percentage              BW 28 d (g) Percentage
Increased Increased
 (sd)  (sd)  (sd)
A 237.8 (20.3) 273.0 (21.7) 14.874% 305.3 (24.2) 28.450%
B 227.5 (10.4) 250.3 (20.1) 9.903% 270.8 (17.8) 18.929%
C 232.7 (8.1) 261.0 (1.0) 12.259% 292.3 (9.5) 25.762%
D 249.3 (32.9) 287.0 (54.8) 14.467% 293.3 (36.7) 17.781%
E 244.0 (19.6) 261.8 (22.8) 7.248% 289.0 (27.8) 18.331%
F 241.0 (17.8) 263.7 (23.3) 9.325% 302.0 (29.5) 25.167%
G 229.3 (19.7) 262.3 (30.0) 14.212% 275.0 (29.5) 19.783%
H 251.8 (24.1) 270.8 (25.3) 7.575% 298.3 (28.5) 18.474%
I 251.0 (34.9) 272.3 (37.5) 8.521% 317.3 (46.2) 26.356%
J 249.3 (21.4) 281.0 (19.0) 12.897% 308.7 (28.4) 23.768%
K 244.3 (18.0) 257.7 (22.6) 5.388% 284.3 (21.0) 16.371%
F test F = 0.562 F = 0.502 F = 2.774 F = 0.844 F = 5.870
(ANOVA) p = 0.829 p = 0.873 p = 0.018 p = 0.593 p < 0.001
Description :   NC = Negative Control   PC = Positive Control
% Increased (Δ )= (The average and standard deviation sd  feed intake at 14 d or 28 d - feed intake at 0 d or 14 d) / 0 d or 14 d feed 
intake x 100 %
 = average     sd= standard deviation
Table 3. Duncan Test Results of Percentage Increased Weight for 14 days  on Male Wistar rats
Group of Treatments
Average Percentage Collumn (%)
1 2 3
K Sibutramine 0.18mg/rat. 1x day 5.388*)   
E Dosage 10mg/rat. 1x day 7.248 7.248
H Dosage 20mg/rat. 1x day 7.575 7.575
I Dosage 10mg/rat. 2x day 8.521 8.521 8.521
F Dosage 5mg/rat. 2x day 9.325 9.325 9.325
B Dosage 5mg/rat. 1x day 9.903 9.903 9.903
C Dosage 2.5mg/rat. 2x day 12.259 12.259
J Dosage 6.7mg/rat. 3x day 12.897 12.897
G Dosage  3.4mg/rat. 3x day 14.212
D Dosage 1.7mg/rat. 3x day 14.467
A Control Neg 0mg/rat. 1x day   14.874
Notes: Treatment results in the same collumn were assumed showed same effects
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Table 4 showed changes in percentage of bodyweight 
in each treatment after 28 days,  And positive control 
showed significant reduction of bodyweight as 
compared to negative control. Most of the treatment 
groups  showed significant reduction of bodyweight 
as compared to group negative control. Group D, 
E, H, B and G showed no significant differences 
with positive control, group K, indicated that those 
treatment groups had similar effect with sibutramine, 
after 28 days of treatment. Group D, PEDSDM 1.7 
mg/rat 3x day (17.781%) and group E, PEDSDM 
dosage 10 mg / rat 1x day (18.331%) showed the least 
increase of percentage of bodyweight gain, mean the 
highest bodyweight loss  after 28 days of treatment. 
Effect of PEDSDM towards Plasma CCK Level 
on Male Wistar rats 
The CCK level showed significant different effects 
(p=0.001) between negative control and all treatments 
after 28 days of administration (Table 5).
Table 4.  Duncan Test Results of Percentage Increase Weight  for 28 days   on Male Wistar  rats
Group of Treatments Analysed Collumn of Average Percentage of Increasing Body 
Weight (in %)
a b c d
K Sibutramine 0.18mg/rat. 1x day 16.371*)    
D PEDSDM Dosage 1.7mg/rat. 3x day 17.781*)
E PEDSDM Dosage 10mg/rat. 1x day 18.331*) 18.331*)
H PEDSDM Dosage 20mg/rat. 1x day 18.474*) 18.474*)
B PEDSDM Dosage 5mg/rat. 1x day 18.929*) 18.929*)
G PEDSDM Dosage  3.4mg/rat. 3xday 19.783*) 19.783*) 19.783*)
J PEDSDM Dosage 6.7mg/rat. 3xday 23.768 23.768
F PEDSDM Dosage 5mg/rat. 2x day 25.167 25.167
C PEDSDM Dosage 2.5mg/rat. 2x day 25.762
I PEDSDM Dosage 10mg/rat. 2x day 26.356
A Neg Control 0mg/rat. 1x day   28.450
Notes: Treatment results in the same collumn were assumed showed same effects 
Table 5. Analysed of Average Plasma CCK level in male Wistar rats after 28 days of treatment
                   
Group of Treatments
CCK (ng/ml)
F p value
X (sd)
A Neg Control 0mg/rat. 1x day 30.13 (1.6) 61.342 <0.001
B PEDSDM Dosage 5mg/rat. 1x day 63.83 (1.6)
C PEDSDM Dosage 2.5mg/rat. 2x day 63.10 (2.3)
D PEDSDM Dosage 1.7mg/rat. 3x day 38.80 (2.7)
E PEDSDM Dosage 10mg/rat. 1x day 69.07 (1.5)
F PEDSDM Dosage 5mg/rat. 2x day 55.23 (1.4)
G PEDSDM Dosage  3.4mg/rat. 3x day 61.93 (2.8)
H PEDSDM Dosage 20mg/rat. 1x day 73.90 (5.1)
I PEDSDM Dosage 10mg/rat. 2x day 62.57 (4.5)
J PEDSDM Dosage 6.7mg/rat. 3x day 60.47 (1.8)
K Sibutramine 0.18mg/rat. 1x day 67.47 (3.7)
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Table 6. Duncan Test results  Plasma CCK Level  in Male Wistar rats
Group of
Treatments
Analysed Collumn of  Average of CCK Plasma (ng/ml)
a b c d e f G
A Negative  Control 30.13
D PEDSDM Dosage 1.7mg/rat. 3x day 38.80
F PEDSDM Dosage 5mg/rat. 2x day 55.23
J PEDSDM Dosage 6.7mg/rat. 3x day 60.47
G PEDSDM Dosage  3.4mg/rat. 3x day 61.93
I PEDSDM Dosage 10mg/rat. 2x day 62.57 62.57
C PEDSDM Dosage 2.5mg/rat. 2x day 63.10 63.10
B PEDSDM Dosage 5mg/rat. 1x day 63.83 63.83
K Sibutramine 0.18mg/rat. 1x day 67.47 67.47
E PEDSDM Dosage 10mg/rat. 1x day 69.07 69.07
H PEDSDM Dosage 20mg/rat. 1x day       73.90
Notes: Treatment results in the same collumn were assumed showed same effects 
Result of  treatment groups there were not in the 
same column with group A, mean there were highly 
significant differences (Table 6). This suggests 
that PEDSDM had effects in increased the plasma 
CCK levels. Group H, PEDSDM dosage 20 mg / rat 
1x day and group E, PEDSDM  dosage of 10 mg 
/ rat 1x day are in the different column compared 
with the positive control group K, showed better of 
CCK plasma levels, 73.90 ng / ml and 69.07 ng / 
ml compared to group K,  67.47 ng / ml, indicated 
greater potential than Sibutramine. 
DISCUSSION
The group that consume the least food intake 14 
days were group B and G, PEDSDM dose 5 mg/rat 
once daily, and dose 3.4 mg/rat three times daily, as 
shown in table 1.  The least result between groups 
once daily for food intake 28 days was group B, 
PEDSDM dosage 5mg/rat/day. Food intake of the 3 
rats in group B  decreased as much as 8g, 6g and 6g 
concomitant with increased CCK plasma level 62.6 
ng/ml, 63.2 ng/ml, and 65.7 ng/ml (respectively), so 
high level of CCK (65.7ng/ml) did not cause better 
decreased food intake  than lower level of CCK (62.6 
ng/ml) (8g),  because rats food intake were influenced 
not only by CCK but several factors and individual 
variation as well, and also there was limitation of 
subject sample (n=3). 
PEDSDM contained high protein level (74.99%). 
Jean et al, stated that daily food intake will decrease 
at condition of high intake of protein diet.14 High 
intake of protein was proved  can suppressed 
appetite and followed by decreased total food intake. 
A metaanalysis  study about energy density reports 
that the highest effect to satiety, is protein, second is 
carbohydrate then followed with fat.15 Hydrolysate 
protein that comes from soybean showed the best 
result in inducing CCK secretion.16 CCK will 
suppress hunger and short time appetite, so that 
animal study will lost hunger and appetite for a mean 
time after being given PEDSDM.
In herbal medicine, higher dosage did not cause better 
effect. This condition often occured, the response 
did not equal with assumption, dosage and predicted 
effects. In herbs, besides main active substance, 
there were another substances, although in a small 
amount, could influence their potency or effect. 
In PEDSDM, besides the main active substances, 
β-conglycinin sub unit β, there were another sub-
unit like β-conglycinin sub unit α and α’, Glycinin 
fraction which has potential  to influence their 
satiety effect.  In low dose, these substances still in 
small amount and not yet influence  the effects. In 
therapeutic dose, these byproduct substances still not 
caused any effects, but in higher dose, it will begin 
ruin the effects of satiety so if we raise the dosage, 
we can’t expect better result.  
The results of average body weight male Wistar rats 
did not show a significant decrease and result of 
statistical analyses did not show a clear significant 
difference among groups of treatment 14 days 
and 28 days (p > 0,05). This is because the rats as 
experimental animals are living creatures, were 
well maintained, appropriate with  ethical aspects of 
research on experimental animals, fed and watered 
ad libitum so that the rats aged 8-10 weeks will grow 
and develop, with an average growth of 5g / day and 
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the adult rat will grow continuously throughout their 
life ( 2-4 years ) but very slow.17 In this study, we 
choose rats aged 8-10 weeks because at that age they 
give optimum physiological responses.
In this study, the phenomena that happened was 
inhibition of weight gain and after the percentage 
result of average body weight changes were 
calculated, among treatment groups showed highly 
significant difference on 14 days of treatments (p = 
0,018),   28 days of treatments (p < 0,001). If we 
compared the body weight graphic between NC 
group and treatments group, there was a difference 
of slope α tangensial, that the graphic of treatment 
groups had a smaller angle (graph more sloping) 
which indicates an increase in body weight that 
occurs is smaller than the negative control group. 
Effect of PEDSDM that happens in this study is 
inhibit the increasing weight gain or controlled body 
weight in male Wistar rats.      
In once daily treatment, the group that showed the 
least result was group E, dosage 10mg/rat once daily, 
food intake of 3 rats in group E was 4g, 7g and 7g 
with CCK level 68,1 ng/ml, 70,8 ng/ml, and 68,3 
ng/ml (average: 69,07 ng/ml). PEDSM dose 10 mg/
rat/day showed good effects to control body weight 
in 14 days, and caused  high level of CCK plasma 
mean the inhibition of weight gain was caused by 
CCK that suppress appetite. In this study, the once 
daily treatment were given at 08.00 a.m so it can be 
concluded that  administration pattern once daily is 
good and also means CCK were good given not in 
divided dose and best given in the morning (08.00 
a.m). This result was appropriate with Merino’s 
study, which stated that CCK primary effects is in 
the morning, assumed that circadian had effects 
towards CCK. Aoyama study stated that rats which 
administered with soybean protein isolated for 14 
days showed dramatically decrease fat and body 
weight compared with rats which given diet casein 
base.18
The best result for 28 days treatment that showed the 
least percentage changes of body weight was group 
D (17,781%) (administration pattern of three times 
daily), had an equal potency with positive control 
sibutramine, as seen in table 3 dan 4. This pattern was 
good in reducing food intake, (24,98%; p = 0,018) as 
seen in table 1.  Treatment for longer time (28 days), 
divided and low dose feeding pattern gave good 
results. The mechanism of weight loss that occurs 
due to PEDSDM involves at least three factors. The 
first is a result of the effects of CCK. At low protein 
dose, it will induce low plasma CCK levels, in this 
study group D showed plasma CCK level at 38.80 
ng/ml was only slightly above the negative controls 
(30.13 ng/ml) but give good result in weight control 
during 28 days. A research states that the effect of 
CCK appears on minimum dosage at 10 mg / kg ( ~ 
100 ng / kg or 25 ng / rat 250g ).19 
Second, weight loss may caused by another active 
components that found in soybean, although the 
number is limited, like Anti Nutrition Factors (ANF). 
Soybean contains  many sort of anti nutrition factors 
(ANF), like trypsin inhibitor, lectin, poliphenol, 
phitic acid, saponin and  antivitamin which have 
negative affects to the absorbtion of food in gastro 
intestinal tract20, although we have not measured 
their contents in the PEDSDM. Previous studies 
mentioned that treatment of PEDSDM during the 
14 days will caused weight loss accompanied by 
atrophy of the villi and significant shortening of 
Lieberkuhn crypt on the jejunum of Wistar rat, while 
the treatments for 28 days symptoms of weight loss 
greater tendency accompanied with jejunal mucosa 
hyperplasia, indicate there is role of ANF. ANF role 
is supported by the fact that plasma CCK levels 
showed no significant difference (p = 0.182) between 
the treatment 14 days and 28 days.21 Third, protein 
in soybean  has thermogenic effects and energy 
expenditure larger than carbohydrates, although the 
mechanism is still not clear entirely.22 One of the 
hypotheses  is soy stimulates quite high release of 
the hormone glucagon. The results of Bensaid study 
showed that administration of high-protein diet 
including soy protein that not restricted (ad libitum) 
for long term significantly decrease food intake and 
white fat mass or white adipose tissue (WAT), and 
this makes soy a good source of nutrients for the 
treatment of obesity.22 
Results of treatment of PEDSDM  against plasma 
CCK levels on male Wistar rats, the comparison 
group (sibutramine) and all treatment groups showed 
highly significant differences with the negative 
control group (Table 5). This suggests that the group 
treatment had effect towards  increasing plasma CCK 
levels. Group H which given PEDSDM dose 20 mg /
rat once a day and group E dosage of 10 mg /rat once 
a day showed  plasma CCK levels greater (73.90 
ng / ml and 69.07 ng / ml) than the positive control 
group K, sibutramine (67. 47 ng / ml) and signifies 
its potential better in increasing  plasma CCK levels. 
This is because sibutramine is not include protein or 
fat, which has the ability to trigger the secretion of 
CCK. 
Vol. 7, No. 1, June 2016 Soybean extract effective dose and Pattern 25
In this study, treatment of PEDSDM dosage of 20 
mg /rat once a day, caused the highest levels of CCK 
plasma (73.90 ng / ml) (Table 5 and Figure 5) but 
showed  only good for weight control  on  14 days 
treatment, while  treatment for 28 days just showed 
moderate effect. This showed that the CCK mainly 
plays a role in weight loss for the treatment of short 
time period (14 days) and better administered in a 
single dosage (not divided pattern) in the morning. 
Effect of CCK lowered portions (meal size) in rats 
that ate as much as they like (feed ad libitum) is 
better than the size of overall food in  fasted rats.23,24 
However CCK in small level have already shown 
effect, referring to another study that says that the 
minimum level of CCK effect was 25 ng/rat, even on 
lower dosage of CCK can show effects in experimental 
animals are fasted or at the time of the morning, it is 
estimated that circadian factors also affect the effect of 
CCK.20,24 In rats that  fed ad libitum, given treatment 
dosage CCK 5-6 (1 μ / rat per dosage) for 5 days, CCK 
lowered portions but no effect on the overall food intake. 
Treatment  of CCK dose 10 mg/kgBW can increase 
levels of CCK (20-40 ng / ml) in blood better compared 
to the average level of CCK after daily eating. CCK-8 
in dosage 10 mg /kgBW showed the effect of towards 
motility and gall bladder contraction accompanied by 
weight loss.23 Nakajima study showed that administration 
of soy peptide β-conglycinin 51-63 high arginine levels 
in intraduodenal shown to decrease food intake through 
increased secretion of CCK on rats.25 
Inconclusion. Administration of PEDSDM at 10 
mg/day once daily  in the morning (08.00 a.m), for 
14 days, showed significant  mean best dose and 
pattern of administration in regulate the bodyweight 
of the rats. While administration of PEDSDM at 
1.7 mg  three times a day, significantly regulate the 
bodyweight of the rats for 28 days.
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